Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Let's pay More.
View:
Post by woundedknee on Feb 17, 2022 8:53am

Let's pay More.

Obviously that heading, "Let's pay more" was sacasm. But this is happening between big Pharma and the FDA according to Project Veritas. It's all there on social media. YouTube, rumble etc. A recording of an FDA official revealed basically that the more you pay the FDA the quicker your drug is approved. In this case they( big pharma) are pushing for an annual booster shot for people 6 months and older that will bring in billions. And this is backed by President Biden. Can TLT compete with those large pockets?
Comment by jicoop on Feb 17, 2022 10:13am
I have been hinting this for years, that the FDA can be persuaded to make certain decisions. Plenty of evidence to find, just google oxycontin + FDA and you find tons of corruption. Thats why we need Health Canada or Europe or Asia to step up and get this through. Little read here : The FDA has never been held to account for its improper handling of the opioid crisis. But the FDA’s conduct is all ...more  
Comment by CancerSlayer on Feb 17, 2022 3:17pm
  The biggest problem imo is the fact that the FDA commissioner is a "political" appointee.  It's never good policy to mix science with politics...imo, such policy simply invites the risk of scientific discovery & public health becoming subordinate to political agendas.  Instead of allowing all miracles of science to be unleashed, many become diminshed/skewed ...more  
Comment by 99942Apophis on Feb 17, 2022 3:46pm
the political shuffle or even worse would be that extreme right or extreme left groups label us as unproven treatment rushed through the system with unknown side effects and miniature tracking devices planted into the patients. 
Comment by CancerSlayer on Feb 17, 2022 4:48pm
  It seems science/drug development has become just another executive branch of Big Govt/Big Pharma...& too often at the expense of the public good.  JMO.
Comment by CancerSlayer on Feb 17, 2022 4:58pm
  Btw, I'm not too worried about the extremists/fringes...unproven treatments that tend to get "rushed through the system" imo are generally tied to Big Pharma/Big Govt interests.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250